These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24932913)

  • 41. Sensitization of GSH synthesis by curcumin curtails acrolein-induced alveolar epithelial apoptosis via Keap1 cysteine conjugation: A randomized controlled trial and experimental animal model of pneumonitis.
    Hee Jo E; Eun Moon J; Han Chang M; Jin Lim Y; Hyun Park J; Hee Lee S; Rae Cho Y; Cho AE; Pil Pack S; Kim HW; Crowley L; Le B; Nukhet AB; Chen Y; Zhong Y; Zhao J; Li Y; Cha H; Hoon Pan J; Kyeom Kim J; Hyup Lee J
    J Adv Res; 2023 Apr; 46():17-29. PubMed ID: 35772713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators.
    Fagnani L; Nazzicone L; Bellio P; Franceschini N; Tondi D; Verri A; Petricca S; Iorio R; Amicosante G; Perilli M; Celenza G
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis.
    Bresinsky M; Strasser JM; Hubmann A; Vallaster B; McCue WM; Fuller J; Singh G; Nelson KM; Cuellar ME; Finzel BC; Ashe KH; Walters MA; Pockes S
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200095. PubMed ID: 35642311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRAS
    Luo L; Zheng T; Wang Q; Liao Y; Zheng X; Zhong A; Huang Z; Luo H
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Novel Covalent XPO1 Inhibitors Based on a Hybrid Virtual Screening Strategy.
    Shen Z; Zhuang W; Li K; Guo Y; Qu B; Chen S; Gao J; Liu J; Xu L; Dong X; Che J; Li Q
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα.
    Borsari C; Keles E; McPhail JA; Schaefer A; Sriramaratnam R; Goch W; Schaefer T; De Pascale M; Bal W; Gstaiger M; Burke JE; Wymann MP
    J Am Chem Soc; 2022 Apr; 144(14):6326-6342. PubMed ID: 35353516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314.
    Bresinsky M; Strasser JM; Vallaster B; Liu P; McCue WM; Fuller J; Hubmann A; Singh G; Nelson KM; Cuellar ME; Wilmot CM; Finzel BC; Ashe KH; Walters MA; Pockes S
    ACS Pharmacol Transl Sci; 2022 Jan; 5(1):20-40. PubMed ID: 35059567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones.
    Gargantilla M; López-Fernández J; Camarasa MJ; Persoons L; Daelemans D; Priego EM; Pérez-Pérez MJ
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-based
    Li Y; Pei J; Lai L
    Chem Sci; 2021 Oct; 12(41):13664-13675. PubMed ID: 34760151
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Howell LA; Beekman AM
    RSC Chem Biol; 2021 Feb; 2(1):215-219. PubMed ID: 34458784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M
    Zaidman D; Gehrtz P; Filep M; Fearon D; Gabizon R; Douangamath A; Prilusky J; Duberstein S; Cohen G; Owen CD; Resnick E; Strain-Damerell C; Lukacik P; ; Barr H; Walsh MA; von Delft F; London N
    Cell Chem Biol; 2021 Dec; 28(12):1795-1806.e5. PubMed ID: 34174194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation.
    Alamri MA; Tahir Ul Qamar M; Afzal O; Alabbas AB; Riadi Y; Alqahtani SM
    J Mol Liq; 2021 May; 330():115699. PubMed ID: 33867606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural modeling and analysis of the SARS-CoV-2 cell entry inhibitor camostat bound to the trypsin-like protease TMPRSS2.
    Escalante DE; Ferguson DM
    Med Chem Res; 2021; 30(2):399-409. PubMed ID: 33564221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.
    Scarpino A; Petri L; Knez D; Imre T; Ábrányi-Balogh P; Ferenczy GG; Gobec S; Keserű GM
    J Comput Aided Mol Des; 2021 Feb; 35(2):223-244. PubMed ID: 33458809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective and Effective: Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors.
    Bianco G; Goodsell DS; Forli S
    Trends Pharmacol Sci; 2020 Dec; 41(12):1038-1049. PubMed ID: 33153778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electron-Deficient Alkynes as Powerful Tools against Root-Knot Nematode
    Tocco G; Eloh K; Laus A; Sasanelli N; Caboni P
    J Agric Food Chem; 2020 Oct; 68(40):11088-11095. PubMed ID: 32924513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Analysis of Bacteriophytochrome Agp2 and Its Engineered Photoactivatable NIR Fluorescent Proteins PAiRFP1 and PAiRFP2.
    Khan FI; Hassan F; Anwer R; Juan F; Lai D
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32906690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL
    Alamri MA; Tahir Ul Qamar M; Mirza MU; Bhadane R; Alqahtani SM; Muneer I; Froeyen M; Salo-Ahen OMH
    J Biomol Struct Dyn; 2021 Aug; 39(13):4936-4948. PubMed ID: 32579061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The design and development of covalent protein-protein interaction inhibitors for cancer treatment.
    Cheng SS; Yang GJ; Wang W; Leung CH; Ma DL
    J Hematol Oncol; 2020 Mar; 13(1):26. PubMed ID: 32228680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted Covalent Inhibition of Telomerase.
    Betori RC; Liu Y; Mishra RK; Cohen SB; Kron SJ; Scheidt KA
    ACS Chem Biol; 2020 Mar; 15(3):706-717. PubMed ID: 32017522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.